The Patent Finder

Genemedicine Co., Ltd.

Also on record
Records under this name other than the patents Genemedicine Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.

Back to Genemedicine Co., Ltd.

PatentTitleStatus Expires Confidence
US 9,920,099Anti-Cancer Compositions Containing WNT Decoy Receptor
Lapsed on the fee record
Ended Mar 20, 2026 · High confidence
Lapsed on the fee recordEnded Mar 20, 2026High confidence
US 9,468,690Decorin gene delivery system and cancer treatment
Term ended
Term ended Feb 24, 2026 · From the USPTO record
Term endedTerm ended Feb 24, 2026From the USPTO record
US 10,046,067Decorin gene delivery system and cancer treatment
Term ended
Ended no later than Feb 24, 2026 · From the USPTO record
Term endedEnded no later than Feb 24, 2026From the USPTO record
US 9,850,500Recombinant adenoviruses capable of regulating angiogenesis
Lapsed on the fee record
Ended Dec 26, 2025 · From the USPTO record
Lapsed on the fee recordEnded Dec 26, 2025From the USPTO record
US 6,423,693Growth hormone releasing hormone expression system and methods of use, including use in animals
Formerly held
Term ended
Term ended Jul 24, 2018 · From the USPTO record
Term endedTerm ended Jul 24, 2018From the USPTO record
US 6,410,228Method for the identification of synthetic cell- or tissue- specific transcriptional regulatory regions
Formerly held
Term ended
Term ended Jul 14, 2018 · From the USPTO record
Term endedTerm ended Jul 14, 2018From the USPTO record
US 7,026,468Process and Equipment for Plasmid Purification
Formerly held
Term ended
Term ended Feb 10, 2018 · Medium confidence
Term endedTerm ended Feb 10, 2018Medium confidence
US 6,103,470Plasmid for delivery of nucleic acids to cells and methods of use
Formerly held
Term ended
Term ended Dec 31, 2017 · From the USPTO record
Term endedTerm ended Dec 31, 2017From the USPTO record
US 6,040,295Formulated nucleic acid compositions and methods of administering the same for gene therapy
Formerly held
Term ended
Term ended Mar 21, 2017 · From the USPTO record
Term endedTerm ended Mar 21, 2017From the USPTO record
US 6,514,947Formulated nucleic acid compositions and methods of administering the same for gene therapy
Formerly held
Term ended
Ended no later than Jan 13, 2015 · From the USPTO record
Term endedEnded no later than Jan 13, 2015From the USPTO record
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited